OtherSep 15, 2026, 12:23 PM
GSK plc Files Form 6-K Incorporating Legal Opinions
AI Summary
GSK plc and GlaxoSmithKline Capital Inc. have filed a Form 6-K report. This filing incorporates by reference two legal opinions from Cleary Gottlieb Steen & Hamilton LLP as exhibits into their existing Registration Statement on Form F-3. The report was signed by Julie Brown, CFO of GSK plc, and Richard John Latchford, VP of GlaxoSmithKline Capital Inc.
Key Highlights
- GSK plc and GlaxoSmithKline Capital Inc. are incorporating exhibits into their Registration Statement on Form F-3.
- Exhibit 5.1: Opinion of Cleary Gottlieb Steen & Hamilton LLP, special U.S. counsel.
- Exhibit 5.2: Opinion of Cleary Gottlieb Steen & Hamilton LLP, special English counsel.
- Julie Brown, Chief Financial Officer and Executive Director of GSK plc, signed the report.
- Richard John Latchford, Vice President of GlaxoSmithKline Capital Inc., signed the report.
Price Impact
More from GSK